From Clinical guidelines — Diagnosis and treatment manual › Chapter 9: Genito-urinary diseases · Médecins Sans Frontières, Current online edition (updated August 2021)
Syndromic management of genital infections for clinicians in resource-limited settings.
- Issuer
- Médecins Sans Frontières
- Edition
- Current online edition (updated August 2021)
- Audience
- Clinicians and healthcare providers working in resource-limited settings
- Evidence
- WHO standardised case management approach
- Reviewed
- 21 Oct 2026 · GMJ
What this guideline says
GMJ summary
This MSF clinical guideline presents a syndromic approach to diagnosing and treating genital infections in resource-limited settings. The guideline addresses the challenges of non-specific clinical features, asymptomatic infections, limited laboratory capacity, and mixed infections by using standardised case management flowcharts based on WHO methodology. Treatment is guided by syndromes (urethral discharge, abnormal vaginal discharge, genital ulcers, venereal warts, and lower abdominal pain in women) rather than laboratory-confirmed pathogens.
Key management principles include treating patients at first encounter without waiting for laboratory results, preferring single-dose regimens, treating sexual partners simultaneously for sexually transmitted infections, and providing risk-reduction counselling with HIV testing. The guideline emphasises that no patient should be sent home without treatment.
A substantial section addresses the comprehensive care of sexual violence survivors, including prophylactic treatments for HIV transmission (antiretroviral therapy within 48–72 hours), pregnancy prevention (levonorgestrel 1.5 mg single dose within 72 hours, extendable to 120 hours), sexually transmitted infection prevention (azithromycin 2 g + ceftriaxone 500 mg), hepatitis B vaccination, and essential mental health support.
Key points
For clinicians — doses and thresholds as stated in the guideline
- Treat patients at first encounter based on syndromic presentation without waiting for laboratory results; no patient should be sent home without treatment
- For emergency contraception after rape: levonorgestrel PO 1.5 mg single dose within 72 hours (extendable to 120 hours); double dose (3 mg) if patient already taking enzyme-inducing drugs
- For STI prevention after sexual violence: azithromycin PO 2 g + ceftriaxone IM 500 mg (or cefixime PO 400 mg) as single doses
- Start antiretroviral post-exposure prophylaxis as early as possible if seen within 48–72 hours after exposure to HIV
- Treat sexual partners simultaneously for urethral discharge, abnormal vaginal discharge (except candidiasis), genital ulcers (except herpes) and sexually transmitted upper genital tract infections
- For candidiasis, genital herpes and venereal warts, treat partner only if symptomatic
- Single-dose regimens are preferred when indicated to improve adherence
- In Schistosoma haematobium endemic areas, consider genitourinary schistosomiasis as a cause of genital symptoms
Presenting symptoms and corresponding syndrome
Table extracted from the guideline
| Presenting symptoms | Syndrome to evaluate |
|---|---|
| Urethral discharge, painful or difficult urination (dysuria) | Urethral discharge |
| Abnormal vaginal discharge, vulvar itching/burning, pain with intercourse (dyspareunia), dysuria | Abnormal vaginal discharge |
| Genital blisters or sores, burning sensation in vulva or perineum | Genital ulcers |
| Skin growths in genital (or anal) area | Venereal warts |
| Lower abdominal pain (in women) | Lower abdominal pain / Upper genital tract infections |
Source: Médecins Sans Frontières, Genital infections — Clinical guidelines — MSF Clinical guidelines. Reproduced in summary form.
From the guideline
Verbatim
“The patient should be treated at his/her first encounter with the health care provider (no patient should be sent home without treatment, e.g. while waiting for laboratory results).”
Editor’s perspective
Why this matters for Georgia and the region
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, Georgian Medical Journal · Chair, Public Health Institute of Georgia · WHO consultant, health and migration
As someone who has worked extensively on sexual and reproductive health in the South Caucasus, I recognise that this MSF syndromic approach addresses a critical gap in our primary care settings where laboratory capacity remains variable. The most important recommendation for Georgian clinicians is the principle of immediate treatment at first encounter—we must overcome the tendency to delay management while awaiting confirmatory tests that may take days or never arrive. The sexual violence protocols are particularly timely given our efforts to strengthen post-exposure care, though implementation will require ensuring that emergency contraception, ceftriaxone and antiretrovirals for post-exposure prophylaxis are actually available at the primary care level, which remains a challenge in rural areas of Georgia, Armenia and Azerbaijan. The caveat about doubling levonorgestrel dose for patients on enzyme-inducing drugs is clinically important but will require training, as many frontline providers are unfamiliar with these drug interactions.
ORCID 0000-0001-7609-4515 · Perspective written for the GMJ Guidelines Library, 21 Oct 2026
Applicability
Georgia and the South Caucasus
This syndromic approach is highly relevant for Georgia and the South Caucasus region, particularly in rural and resource-limited primary care settings where laboratory capacity for STI diagnosis may be limited. Georgia’s national sexual and reproductive health programmes would need to adapt these protocols to local antimicrobial resistance patterns, particularly for gonorrhoea, and integrate them with existing HIV testing services and gender-based violence response systems. The sexual violence protocols are particularly pertinent given ongoing needs for standardised post-exposure care in conflict-affected areas of the region, and should be aligned with national emergency contraception availability and hepatitis B vaccination schedules already in use across Georgia, Armenia and Azerbaijan.
Questions this guideline answers
Quick answers
Should I wait for laboratory results before treating a patient with genital discharge?
No. Patients should be treated at their first encounter with the healthcare provider based on syndromic presentation. Laboratory tests should never delay treatment, and results should be available within one hour if performed. No patient should be sent home without treatment.
When should I treat the sexual partner of a patient with genital infection?
Treat partners simultaneously for urethral discharge, abnormal vaginal discharge (except candidiasis), genital ulcers (except herpes), and sexually transmitted upper genital tract infections. For candidiasis, genital herpes and venereal warts, treat the partner only if symptomatic.
What prophylactic treatment should I give to a sexual violence survivor seen 36 hours after assault?
Provide: (1) HIV post-exposure prophylaxis (antiretroviral therapy, as within 48–72-hour window); (2) emergency contraception (levonorgestrel 1.5 mg single dose); (3) STI prevention (azithromycin 2 g PO + ceftriaxone 500 mg IM as single doses); and (4) hepatitis B vaccination (accelerated schedule). Mental health support is essential.
Can I still give emergency contraception if the patient presents 96 hours (4 days) after rape?
Yes. Although ideally given within 72 hours, emergency contraception (levonorgestrel or ulipristal) is still sufficiently effective to be administered between 72 and 120 hours (5 days) after rape.
Related on GMJ
Interconnected resources
Dictionary of Public Health
Drugs A–Z
GMJ News coverage
Quality & accreditation
Same guideline
- Acute prostatitis — MSF Clinical guidelinesChapter 9: Genito-urinary diseases
- Acute pyelonephritis — MSF Clinical guidelinesChapter 9: Genito-urinary diseases
- Acute cystitis — MSF Clinical guidelinesChapter 9: Genito-urinary diseases
- Acute diarrhoea — MSF Clinical guidelinesChapter 3: Gastrointestinal disorders
Other guidelines on this topic
- Disseminated or miliary tuberculosis — MSF Tuberculosis
- Acute cystitis — MSF Clinical guidelines
- Promoting health equity, gender and ethnic equality, and human rights in COVID-19 responses: Key considerations
- Key Considerations for Integrating Gender Equality into Health Emergency and Disaster Response: COVID-19
- Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
- Issuer
- Médecins Sans Frontières
- Guideline
- Clinical guidelines — Diagnosis and treatment manual
- Chapter
- Chapter 9: Genito-urinary diseases
- Type
- Clinical guideline (chapter)
- Edition
- Current online edition (updated August 2021)
- Status
- Current
- Published
- 2026-10-14
- Scope
- Syndromic management of genital infections including urethral discharge, vaginal discharge, genital ulcers, venereal warts, and upper genital tract infections; comprehensive care for sexual violence survivors
- Audience
- Clinicians and healthcare providers working in resource-limited settings
- Evidence
- WHO standardised case management approach
- Record history
- Created 21 Oct 2026 · updated 21 Oct 2026 · next check Apr 2027
Médecins Sans Frontières. Genital infections. In: Clinical guidelines — Diagnosis and treatment manual [Internet]. Paris: MSF; 2021 Aug [cited 2026 Oct 14]. Available from: https://medicalguidelines.msf.org/en/viewport/CG/english/genital-infections-23536743.htmlGMJ Guidelines Library records are original summaries written by the GMJ editorial team from the issuer’s published document and reviewed by a physician. They do not replace the full guideline. The document is the copyright of its issuer and is linked, not hosted. Spotted an error or a newer edition? Tell the Guidelines Desk.
Was this article helpful?

